ALEXANDER NORWOOD: Open Payments
NPI 1013545631 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 31 payments from 8 companies in 2025. Trend: 2023 $4,690 · 2024 $405 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $324 |
| EMD Serono, Inc. | 7 | $286 |
| UCB, Inc. | 5 | $223 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ARGENX US, INC. | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Genentech USA, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Nayzilam, UBRELVY, QULIPTA, AIRSUPRA, Mavenclad, VYVGART HYTRULO, AUSTEDO XR, Ocrevus Zunovo.
Industry payments across OH — which companies pay providers there.
